Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

Also called NCT01858428

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01858428
Other papers using this trial's data
  • Stellarex Drug-Coated Balloon for the Treatment of Peripheral Artery Disease: Five-Year Results from the ILLUMENATE Pivotal Randomized Controlled Trial The American journal of cardiology, 2024-09-15 DOI, PubMed 39019203

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01858428. Randomized; single masking; primary purpose treatment. Start 2013-06-18 (actual); primary completion 2016-09 (actual). Results posted on 2018-01-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon
Acronym
ILLUMENATE
Condition
Peripheral Arterial Disease
Intervention (Device)
Cardiovascular Ingenuity (CVI) Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter
Intervention (Device)
EverCross Percutaneous Transluminal Balloon Catheter
Lead sponsor
Spectranetics Corporation (class: industry)

Record details

Record id
cardio:ct-nct01858428
Content hash
29fc8dec1704051ea540d3d70ff46d763d5ecbe808338066572024472d6cb050